Literature DB >> 29109757

Evaluation of the efficacy of Ajuga decumbens extract supplement in individuals with knee discomfort associated with physical activity: A randomized, double-blind, placebo-controlled study.

Yoko Sawada1, Atsushi Sugimoto1, Takehito Hananouchi2, Norimasa Sato3, Isao Nagaoka4.   

Abstract

The aim of the present study was to assess the efficacy and safety of the oral administration of Ajuga decumbens extract (ADE) supplement to individuals with knee discomfort associated with physical activity. A randomized, double-blind, placebo-controlled study was conducted using 48 subjects. The subjects were randomly allocated to an ADE diet group (oral administration of ADE-containing diet, n=24) or a placebo group (n=24), and the intervention was conducted for 12 weeks. A total of 22 subjects in the placebo group and 22 subjects in the ADE diet group were assessed to be eligible for assessment of the efficacy of supplement. Knee function was assessed by changes in the scores of the Japanese Knee Osteoarthritis Measure (JKOM) questionnaire and the scores of the Japan Orthopedic Association (JOA) criteria, as well as by analyzing the levels of type II collagen synthesis and degradation biomarkers (procollagen II C-terminal propeptide, cross-linked C-telopeptide of type II collagen, collagen type II cleavage and matrix metalloproteinase-13). Outcomes were measured at the baseline and at 4, 8 and 12 weeks from the start of administration. Subscale II (joint flexion/stiffness) of the JOA criteria was markedly improved in the ADE diet group compared with the placebo group at 8 and 12 weeks during the intervention. Furthermore, in the subgroup analyses using subjects with mild knee discomfort, subscale II (pain/stiffness) and IV (general activities) scores of JKOM were significantly improved (P<0.05) and total JKOM score was markedly improved in the ADE diet group compared with the placebo group at week 8 of the intervention. No adverse effects were identified for the administration of ADE. In conclusion, these observations suggest that the administration of an ADE-containing diet is safe and improves joint function (flexion and stiffness) and general activity in subjects with mild knee discomfort. Therefore, ADE could be a promising candidate as a functional food that is beneficial to joint health.

Entities:  

Keywords:  Ajuga decumbens; biomarker; cartilage metabolism; functional food; joint health; osteoarthritis score

Year:  2017        PMID: 29109757      PMCID: PMC5658745          DOI: 10.3892/etm.2017.5064

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study.

Authors:  Noriko Yoshimura; Shigeyuki Muraki; Hiroyuki Oka; Akihiko Mabuchi; Yoshio En-Yo; Munehito Yoshida; Akihiko Saika; Hideyo Yoshida; Takao Suzuki; Seizo Yamamoto; Hideaki Ishibashi; Hiroshi Kawaguchi; Kozo Nakamura; Toru Akune
Journal:  J Bone Miner Metab       Date:  2009-07-01       Impact factor: 2.626

3.  Effect of non-steroidal anti-inflammatory drugs on course of osteoarthritis.

Authors:  S Rashad; F Low; P Revell; A Hemingway; K Rainsford; F Walker
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

4.  An outcome measure for Japanese people with knee osteoarthritis.

Authors:  Masami Akai; Tokuhide Doi; Keiji Fujino; Tsutomu Iwaya; Hisashi Kurosawa; Teruo Nasu
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

5.  A new marker for osteoarthritis: cross-sectional and longitudinal approach.

Authors:  M Reijman; J M W Hazes; S M A Bierma-Zeinstra; B W Koes; S Christgau; C Christiansen; A G Uitterlinden; H A P Pols
Journal:  Arthritis Rheum       Date:  2004-08

6.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

7.  Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

Authors:  S Christgau; Y Henrotin; L B Tankó; L C Rovati; J Collette; O Bruyere; R Deroisy; J Y Reginster
Journal:  Clin Exp Rheumatol       Date:  2004 Jan-Feb       Impact factor: 4.473

8.  Evidence for altered synthesis of type II collagen in patients with osteoarthritis.

Authors:  F Nelson; L Dahlberg; S Laverty; A Reiner; I Pidoux; M Ionescu; G L Fraser; E Brooks; M Tanzer; L C Rosenberg; P Dieppe; A Robin Poole
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

9.  The effect of glucosamine supplementation on people experiencing regular knee pain.

Authors:  R Braham; B Dawson; C Goodman
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

10.  Evaluation of the effect of glucosamine administration on biomarkers for cartilage and bone metabolism in soccer players.

Authors:  Masafumi Yoshimura; Koji Sakamoto; Akifumi Tsuruta; Tetsuro Yamamoto; Kaori Ishida; Hideyo Yamaguchi; Isao Nagaoka
Journal:  Int J Mol Med       Date:  2009-10       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.